Empowering innovative science and transformativetherapeutics

We are a leading life sciences investor financing highly innovative companies worldwide.

We provide biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs.

We invest in companies that will have a positive impact on patients and society.

Latest:
new fund closed

26.05.2021

Ysios Capital closes its third fund at €216 million ($260 million)

expertise

A diverse and
experienced team
driving the future
of health

The scientific, financial and entrepreneurial
expertise of our international team has proven
instrumental to the development of many thriving
biotech ventures.

We are united by our commitment to achieving
success for new, promising companies.

    perform

    Global outlook
    Proven performance

    >€400M

    Assets under
    management

    34

    Invested
    companies

    14

    Products brought
    to market

    >40

    Products at
    clinical stage

    breakthrough

    Backing the
    breakthroughs
    of tomorrow

    Our portfolio features an exciting mix of biotech
    companies located across Europe and the United
    States, all of which have a high potential to make
    a meaningful impact.

    latest